Golden State Wealth Management, LLC Recursion Pharmaceuticals, Inc. Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 385 shares of RXRX stock, worth $2,891. This represents 0.0% of its overall portfolio holdings.
Number of Shares
385Holding current value
$2,891% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$255 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$243 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$187 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$130 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$110 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.36B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...